Afelimomab

Afelimomab (MAK 195F) is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.^[1][2]

Afelimomab

Monoclonal antibody
Type	F(ab')2 fragment
Source	Mouse
Target	TNFα
Clinical data
ATC code	L04AB03 (WHO)
Identifiers
CAS Number	156227-98-4 N
ChemSpider	none
UNII	6SC756X51V
KEGG	D07436 Y
NY (what is this?)  (verify)